Rallybio Corp (RLYB) — Financial Flexibility Index
Rallybio Corp (RLYB) has a Financial Flexibility Index of -1.90x as of March 2026. Free cash flow of $-7.98 Million (operating CF $-7.98 Million minus capex $0.00) represents -2% of total liabilities ($4.20 Million). Check RLYB capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rallybio Corp Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Rallybio Corp across 7 annual periods. See RLYB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rallybio Corp (2019–2025)
Year-by-year free cash flow to debt coverage for Rallybio Corp. For the full company profile including market capitalisation, see Rallybio Corp (RLYB) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.93x | $-29.81 Million | $-29.81 Million | $4.30 Million | ▲ +9.3% |
| 2024 | -7.64x | $-49.28 Million | $-49.28 Million | $6.45 Million | ▼ -19.6% |
| 2023 | -6.39x | $-60.25 Million | $-60.27 Million | $9.44 Million | ▼ -24.0% |
| 2022 | -5.15x | $-57.23 Million | $-57.28 Million | $11.12 Million | ▲ +25.0% |
| 2021 | -6.87x | $-45.20 Million | $-45.53 Million | $6.58 Million | ▼ -83.6% |
| 2020 | -3.74x | $-21.90 Million | $-22.04 Million | $5.86 Million | ▼ -19.7% |
| 2019 | -3.13x | $-14.84 Million | $-15.03 Million | $4.75 Million | — |